XML 100 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 45 $ (172) $ 68,574,621 $ (48,265,324) $ 20,309,170
Balance (in Shares) at Dec. 31, 2022 446,290          
Balance (in Shares) at Dec. 31, 2022   1,550        
Stock-based compensation expense recovery 160,010 160,010
Vesting of restricted stock 299,656 299,656
Vesting of restricted stock (in Shares) 4,334          
Issuance of common stock through exercise of stock options 70,889 70,889
Issuance of common stock through exercise of stock options (in Shares) 3,545          
Unrealized loss on available-for-sale securities 840 840
Net loss (11,099,488) (11,099,488)
Balance at Dec. 31, 2023 $ 45 $ (172) 69,105,176 840 (59,364,812) $ 9,741,077
Balance (in Shares) at Dec. 31, 2023 454,169         454,169
Balance (in Shares) at Dec. 31, 2023   1,550       1,550
Stock-based compensation expense recovery 45,871 $ 45,871
Repurchase of common stock purchase warrants exercisable under PIPE Warrants (52,500) (52,500)
Issuance of common stock in connection with At The Market Offering Agreement $ 2 138,485 138,487
Issuance of common stock in connection with At The Market Offering Agreement (in Shares) 18,899          
Offering costs in connection with At the Market Offering Agreement (204,845) (204,845)
Vesting of restricted stock 48,054 48,054
Vesting of restricted stock (in Shares) 438          
Unrealized loss on available-for-sale securities (799) (799)
Net loss (2,902,117) (2,902,117)
Balance at Mar. 31, 2024 $ 47 $ (172) 69,080,241 41 (62,266,929) 6,813,228
Balance (in Shares) at Mar. 31, 2024 473,506          
Balance (in Shares) at Mar. 31, 2024   1,550        
Balance at Dec. 31, 2023 $ 45 $ (172) 69,105,176 840 (59,364,812) $ 9,741,077
Balance (in Shares) at Dec. 31, 2023 454,169         454,169
Balance (in Shares) at Dec. 31, 2023   1,550       1,550
Unrealized loss on available-for-sale securities           $ (840)
Net loss           (5,011,141)
Balance at Jun. 30, 2024 $ 65 $ (172) 70,465,344 (64,375,953) 6,089,284
Balance (in Shares) at Jun. 30, 2024 654,789          
Balance (in Shares) at Jun. 30, 2024   1,550        
Balance at Dec. 31, 2023 $ 45 $ (172) 69,105,176 840 (59,364,812) $ 9,741,077
Balance (in Shares) at Dec. 31, 2023 454,169         454,169
Balance (in Shares) at Dec. 31, 2023   1,550       1,550
Stock-based compensation expense recovery 101,844 $ 101,844
Repurchase of common stock purchase warrants exercisable under PIPE Warrants 0 (52,500) (52,500)
Issuance of common stock $ 13 398,429 398,442
Issuance of common stock (in Shares) 132,814          
Issuance of common stock in connection with At The Market Offering Agreement $ 20 1,494,394 1,494,414
Issuance of common stock in connection with At The Market Offering Agreement (in Shares) 199,004          
Issuance of common stock through exercise of prefunded warrants $ 74 4,599,948 4,600,022
Issuance of common stock through exercise of prefunded warrants (in Shares) 734,221          
Offering costs in connection with At the Market Offering Agreement (255,288) (255,288)
Offering costs in connection with issuance of common shares and warrants (366,189) (366,189)
Reverse stock split adjustment $ 18 (18)
Reverse stock split adjustment (in Shares) 174,738          
Vesting of restricted stock 147,831 147,831
Vesting of restricted stock (in Shares) 1,958          
Issuance of common stock through exercise of stock options          
Unrealized loss on available-for-sale securities (840) (840)
Net loss (12,497,805) (12,497,805)
Balance at Dec. 31, 2024 $ 170 $ (172) 75,173,627 (71,862,617) $ 3,311,008
Balance (in Shares) at Dec. 31, 2024 1,696,904         1,696,904
Balance (in Shares) at Dec. 31, 2024   1,550       1,550
Balance at Mar. 31, 2024 $ 47 $ (172) 69,080,241 41 (62,266,929) $ 6,813,228
Balance (in Shares) at Mar. 31, 2024 473,506          
Balance (in Shares) at Mar. 31, 2024   1,550        
Stock-based compensation expense recovery 34,834 34,834
Issuance of common stock in connection with At The Market Offering Agreement $ 18 1,355,909 1,355,927
Issuance of common stock in connection with At The Market Offering Agreement (in Shares) 180,105          
Offering costs in connection with At the Market Offering Agreement (50,443) (50,443)
Vesting of restricted stock 44,803 44,803
Vesting of restricted stock (in Shares) 1,178          
Unrealized loss on available-for-sale securities (41) (41)
Net loss (2,109,024) (2,109,024)
Balance at Jun. 30, 2024 $ 65 $ (172) 70,465,344 (64,375,953) 6,089,284
Balance (in Shares) at Jun. 30, 2024 654,789          
Balance (in Shares) at Jun. 30, 2024   1,550        
Balance at Dec. 31, 2024 $ 170 $ (172) 75,173,627 (71,862,617) $ 3,311,008
Balance (in Shares) at Dec. 31, 2024 1,696,904         1,696,904
Balance (in Shares) at Dec. 31, 2024   1,550       1,550
Stock-based compensation expense recovery 1,158   $ 1,158
Issuance of common stock through exercise of prefunded warrants $ 80 (80)    
Issuance of common stock through exercise of prefunded warrants (in Shares) 799,631          
Vesting of restricted stock 14,743   14,743
Vesting of restricted stock (in Shares) 152          
Net loss   (1,658,396) (1,658,396)
Balance at Mar. 31, 2025 $ 250 $ (172) 75,189,448   (73,521,013) 1,668,513
Balance (in Shares) at Mar. 31, 2025 2,496,687          
Balance (in Shares) at Mar. 31, 2025   1,550        
Balance at Dec. 31, 2024 $ 170 $ (172) 75,173,627 (71,862,617) $ 3,311,008
Balance (in Shares) at Dec. 31, 2024 1,696,904         1,696,904
Balance (in Shares) at Dec. 31, 2024   1,550       1,550
Issuance of common stock through exercise of stock options          
Unrealized loss on available-for-sale securities          
Net loss           (2,705,639)
Balance at Jun. 30, 2025 $ 250 $ (172) 75,190,151   (74,568,256) $ 621,973
Balance (in Shares) at Jun. 30, 2025 2,496,873         2,496,873
Balance (in Shares) at Jun. 30, 2025   1,550       1,550
Balance at Mar. 31, 2025 $ 250 $ (172) 75,189,448   (73,521,013) $ 1,668,513
Balance (in Shares) at Mar. 31, 2025 2,496,687          
Balance (in Shares) at Mar. 31, 2025   1,550        
Stock-based compensation expense recovery (66)   (66)
Offering costs in connection with the on-going Public Offering (1,100)   (1,100)
Vesting of restricted stock 1,869   1,869
Vesting of restricted stock (in Shares) 186          
Unrealized loss on available-for-sale securities          
Net loss   (1,047,243) (1,047,243)
Balance at Jun. 30, 2025 $ 250 $ (172) $ 75,190,151   $ (74,568,256) $ 621,973
Balance (in Shares) at Jun. 30, 2025 2,496,873         2,496,873
Balance (in Shares) at Jun. 30, 2025   1,550       1,550